Abstract

Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.

Highlights

  • Tau filament deposition in Alzheimer disease (AD),2 frontotemporal dementia (FTD), and other tauopathies correlates closely with cognitive dysfunction and cell death [1]

  • AD is characterized by memory loss that derives from involvement of hippocampal neurons, whereas FTD is characterized

  • Tau-yellow fluorescent protein (YFP) co-localized with microtubules (Fig. 1, B and F), as others have reported [22, 23], and did not readily form inclusions

Read more

Summary

EXPERIMENTAL PROCEDURES

Tau Expression, Purification, and Fibrillization—The MTBR (amino acids 243–375) of full-length (P10636-8) wild-type tau (a gift from Dr Virginia Lee) was subcloned into pRK172. HAtagged MTBR Tau contains the sequence YPYDVPDYA on its C terminus. Recombinant Tau MTBR was prepared as described previously from Rosetta (DE3)pLacI competent cells (Novagen), exploiting the heat stability of Tau protein followed by cation exchange chromatography [19]. Single-use aliquots were stored at Ϫ80 °C in 10 mM HEPES and 100 mM NaCl (pH 7.4). To induce fibrillization of Tau monomer, the MTBR was incubated at room temperature without agitation in 5 mM dithiothreitol, 10 mM HEPES (pH 7.4), 100 mM NaCl, and 150 ␮M arachidonic acid (Sigma). Incubation times from 3 to 24 h produced similar results

Extracellular to Intracellular Propagation of Tau Misfolding
RESULTS
To verify that the Tau present after trypsinization was indeed
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call